ArriVent BioPharma, Inc. Common Stock
Status: Publicly traded
Direct answer
ArriVent BioPharma, Inc. Common Stock is publicly traded on NASDAQ under the ticker AVBP.
ArriVent BioPharma, Inc. is a clinical-stage biopharmaceutical firm dedicated to discovering, advancing, and bringing to market treatments addressing critical gaps in cancer patient care. The company specifically focuses on developing and commercializing targeted oncology therapies for conditions like non-small-cell lung cancer (NSCLC) and various solid tumor indications. Among its pipeline candidates are...
Can you invest in ArriVent BioPharma, Inc. Common Stock?
Yes. ArriVent BioPharma, Inc. Common Stock is publicly traded on NASDAQ under the ticker AVBP.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for ArriVent BioPharma, Inc. Common Stock
Detailed equity research is provided by MarketSnap.